NAD+ augmentation therapy

NAD+ augmentation therapy has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Jan 27, 2026: “The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation”.

Intervention

1 paper studies it3 findingsUpdated

See all 1 papers on NAD+ augmentation therapy

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Blood NAD increased slowly, plateauing after approximately two weeks of treatment”
The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementationiScience2026doi:10.1016/j.isci.2026.114764

1 of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • 1 finding against
  • Funders: Dam Foundation and 5 more
  • 3 of 3 findings with company ties
  • Human trial1

Studies in people

1 study gave NAD+ augmentation therapy to people and measured what changed.

What changedDesignPeopleSource

up: Increases blood NAD+ concentration

up: Increases cerebral NAD+

down: Decreases blood NAD+ concentration

Trialapproximately two weeks to plateau6 peopleBothAfter treatment discontinuationiScience, Jan 27, 2026

What did studies of NAD+ augmentation therapy find?

2

Studies of NAD+ augmentation therapy measured 2 outcomes: blood NAD+ concentration and cerebral NAD+.

Blood NAD+ concentration

downin humans1upin humans1

1 study
  1. NAD+ augmentation therapy decreases blood NAD+ concentration in humans after treatment discontinuation.

    “declined with similarly slow kinetics following treatment discontinuation”

    Human trialafter treatment discontinuationoral NAD precursorsbloodn = 6

    The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation

    iScience

  2. NAD+ augmentation therapy increases blood NAD+ concentration in humans.

    “Blood NAD increased slowly, plateauing after approximately two weeks of treatment”

    Human trialoral NAD precursorsblood1,200 mg/dayapproximately two weeks to plateaun = 6

    The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation

    iScience

More on Blood NAD+ concentration

Cerebral NAD+

upin humans1

1 study
  1. NAD+ augmentation therapy increases cerebral NAD+ in humans.

    “Cerebral NAD levels increased measurably after four weeks of treatment”

    Human trialoral NAD precursorsbrain1,200 mg/dayfour weeksn = 6

    The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation

    iScience

More on Cerebral NAD+

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months